BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells

被引:0
|
作者
Ryan T Phan
Masumichi Saito
Katia Basso
Huifeng Niu
Riccardo Dalla-Favera
机构
[1] Institute for Cancer Genetics,Department of Pathology, Department of Genetics and Development and the Herbert Irving Comprehensive Cancer Center
[2] Columbia University,Children's Hospital, Center for Blood Research
[3] Harvard University Medical School,undefined
[4] Roche Institute of Molecular Biology,undefined
来源
Nature Immunology | 2005年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The BCL6 proto-oncogene encodes a transcriptional repressor that is required for germinal center formation and has been linked to lymphomagenesis. BCL6 functions by directly binding to specific DNA sequences and suppressing the transcription of target genes. Here we report an alternative mechanism by which BCL6 controls the transcription of genes lacking a BCL6 binding site and show that this mechanism was required for the prevention of tumor suppressor p53–independent cell cycle arrest in germinal center B cells. BCL6 interacted with the transcriptional activator Miz-1 and, via Miz-1, bound to the promoter and suppressed transcription of the cell cycle arrest gene CDKN1A. Through this mechanism, BCL6 may facilitate the proliferative expansion of germinal centers during the normal immune response and, when deregulated, the pathological expansion of B cell lymphomas.
引用
收藏
页码:1054 / 1060
页数:6
相关论文
共 50 条
  • [1] BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells
    Phan, RT
    Saito, M
    Basso, K
    Niu, HF
    Dalla-Favera, R
    NATURE IMMUNOLOGY, 2005, 6 (10) : 1054 - 1060
  • [2] A role for the cyclin-dependent kinase inhibitor p21 in the G(1) cell cycle arrest mediated by the type I interferons
    Subramaniam, PS
    Johnson, HM
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (01): : 11 - 15
  • [3] P21 CYCLIN-DEPENDENT KINASE INHIBITOR INHIBITS INTIMAL LESIONS THROUGH CELL-CYCLE ARREST AND DIFFERENTIATION OF VASCULAR CELLS
    YANG, ZY
    PERKINS, ND
    SIMARI, RD
    SAN, H
    GORDON, D
    NABEL, GJ
    NABEL, EG
    CIRCULATION, 1995, 92 (08) : 2381 - 2381
  • [4] Transcriptional regulation of cyclin-dependent kinase inhibitor 1A (P21) by the transcription factor AP-2γ
    Scibetta, A. G.
    Canosa, M.
    Hurst, H. C.
    BREAST CANCER RESEARCH, 2010, 12 : S7 - S7
  • [5] Transcriptional regulation of cyclin-dependent kinase inhibitor 1A (P21) by the transcription factor AP-2γ
    AG Scibetta
    M Canosa
    HC Hurst
    Breast Cancer Research, 12
  • [6] CELL-CYCLE EXPRESSION AND P53 REGULATION OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P21
    LI, Y
    JENKINS, CW
    NICHOLS, MA
    XIONG, Y
    ONCOGENE, 1994, 9 (08) : 2261 - 2268
  • [7] Transforming growth factor β1 promotes cell cycle exit through the cyclin-dependent kinase inhibitor p21 in the developing cerebral cortex
    Siegenthaler, JA
    Miller, MW
    JOURNAL OF NEUROSCIENCE, 2005, 25 (38): : 8627 - 8636
  • [8] Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21/WAF1/CIP1
    Srivastava, Rakesh K.
    Chen, Qinghe
    Siddiqui, Imtiaz
    Sarva, Krishna
    Shankar, Sharmila
    CELL CYCLE, 2007, 6 (23) : 2953 - 2961
  • [9] Interaction of the cyclin-dependent kinase inhibitor p21 with PCNA: A link between cell cycle and DNA repair
    Cayrol, C
    Ducommun, B
    M S-MEDECINE SCIENCES, 1997, 13 (11): : 1259 - 1265
  • [10] The role of the cyclin-dependent kinase inhibitor p21(WAF1) in the maintenance of differentiating hepatoma cells
    Ebinuma, H
    Saito, H
    Tada, S
    Kurose, I
    Kaneko, F
    Takahashi, M
    Ohishi, T
    Watanabe, T
    Ishii, H
    GASTROENTEROLOGY, 1997, 112 (04) : A1259 - A1259